Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Information tools for exploratory data analysis in population pharmacokinetics.

O Petricoul1, L Claret, D Barbolosi

  • 1UPRES EA-3286, Faculty of Pharmacy, Marseille, France.

Journal of Pharmacokinetics and Pharmacodynamics
|May 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clamped percutaneous Poller screws to assist intramedullary nailing of proximal third tibia shaft fractures.

Annals of the Royal College of Surgeons of England·2022
Same author

Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer.

Scientific reports·2019
Same author

Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chess.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.

British journal of cancer·2017
Same author

Model-Based Estimates of Tumor Growth Inhibition Metrics Are Time-Independent: A Reply to Mistry.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma.

Clinical pharmacology and therapeutics·2016

Population pharmacokinetic studies analyze drug variability. Information theory indexes enhance model selection, identify atypical individuals, and screen covariates for optimal drug use and safety.

Area of Science:

  • Pharmacokinetics
  • Pharmacometrics
  • Drug Development

Background:

  • Population pharmacokinetic (Pop-PK) studies characterize interindividual variability using statistical distributions.
  • Pop-PK data analysis is crucial for drug safety, guiding future research and clinical practice.
  • Existing statistical and graphical methods have limitations in comprehensive Pop-PK data analysis.

Purpose of the Study:

  • To introduce information theory indexes as complementary tools for Pop-PK data analysis.
  • To demonstrate the utility of these indexes in model selection, outlier detection, and covariate screening.
  • To validate the application of information theory indexes using simulated and real-world Pop-PK data.

Main Methods:

  • Application of information theory indexes to population pharmacokinetic data.

Related Experiment Videos

  • Utilizing indexes for selecting the most appropriate statistical distribution model.
  • Employing indexes to detect atypical individuals (outliers) within the population.
  • Using indexes to screen for influential covariates affecting drug disposition.

    • Main Results:

    • Information theory indexes effectively aid in selecting the best-fit statistical distribution model for Pop-PK data.
    • These indexes successfully identify individuals with atypical pharmacokinetic profiles.
    • The methodology proves efficient in screening for covariates that significantly influence drug pharmacokinetics.
    • Validation confirmed the robustness of the approach with both simulated and real datasets.

    Conclusions:

    • Information theory indexes offer a valuable, complementary approach to traditional Pop-PK data analysis techniques.
    • These indexes enhance the precision of model selection, outlier identification, and covariate screening.
    • The application of information theory indexes can lead to more refined drug development and personalized medicine strategies.